Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Conditions:   Drug-resistant Tuberculosis;   HIV Coinfection;   Cost-Benefit Analysis Intervention:   Diagnostic Test: Targeted next-generation sequencing Sponsors:   University of California, San Francisco;   University of Stellenbosch;   National Health Laboratory Service (NHLS), South Africa;   National Institute for Communicable Diseases, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID);   Find;   Translational Ge nomics Research Institute;   University Hospital Heidelberg Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials